Skip to main content
. Author manuscript; available in PMC: 2007 May 2.
Published in final edited form as: Cancer Res. 2005 May 1;65(9):3883–3893. doi: 10.1158/0008-5472.CAN-04-3757

Figure 4.

Figure 4

The synergistic increase in acetylated tubulin caused by lonafarnib and paclitaxel treatment correlates with FT inhibition and mitotic arrest. A, Western blot analysis for acetylated tubulin, HDJ-2 (N, non-farnesylated band; F, farnesylated band), and total tubulin following lonafarnib and/or paclitaxel treatment over time. B, percent mitosis assessed by DNA staining, done in parallel and with the same drug treatments over time as in A. Bars, SD.